News: Zimmer Holdings Inc (ZMH.N)

ZMH.N on New York Stock Exchange

114.68USD
12:17pm EST
Price Change (% chg)

$-0.26 (-0.23%)
Prev Close
$114.94
Open
$115.16
Day's High
$116.00
Day's Low
$114.30
Volume
255,708
Avg. Vol
269,730
52-wk High
$116.00
52-wk Low
$90.48

Search Stocks
Select another date:

Thu, Dec 4 2014

EU mergers and takeovers (Dec 4)

BRUSSELS, Dec 4 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

EU mergers and takeovers (Nov 18)

BRUSSELS, Nov 18 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

EU regulators extend Zimmer, Biomet deal deadline to March 11

BRUSSELS - European Union antitrust regulators will decide on U.S. medical device maker Zimmer's $13.4 billion bid for Biomet [LVBHAB.UL] by March 11, a three-week extension from the previous deadline, the European Commission said on Friday.

EU regulators extend Zimmer, Biomet deal deadline to March 11

BRUSSELS, Oct 10 - European Union antitrust regulators will decide on U.S. medical device maker Zimmer's $13.4 billion bid for Biomet by March 11, a three-week extension from the previous deadline, the European Commission said on Friday.

Deals of the day- Mergers and acquisitions

(Adds Zimmer, Medtronic, TIM Participações, Comcast, Chiquita, JPMorgan Chase & Co, Fortress and Ilva)

EU regulators open extensive probe into Zimmer, Biomet deal

BRUSSELS - European Union antitrust regulators opened on Friday an extensive investigation into U.S. medical device maker Zimmer's $13.4 billion bid for Biomet [LVBHAB.UL], increasing the pressure on Zimmer to offer concessions to allay their concerns.

UPDATE 1-EU regulators open extensive probe into Zimmer, Biomet deal

* Zimmer may have to offer concessions in return for EU okay

EU regulators open extensive probe into Zimmer, Biomet deal

BRUSSELS, Oct 3 - European Union antitrust regulators opened on Friday an extensive investigation into U.S. medical device maker Zimmer's bid for Biomet , concerned that the $13.4 billion deal may lead to more expensive orthopaedic products.

Deals of the day- Mergers and acquisitions

(Adds SoftBank, JPMorgan Chase & Co, Zimmer Holdings, Vodafone Qatar, Volksbanken AG, Enel, UniCredit Bank Austria, Anadarko Petroleum and Alere)

EU to extend Zimmer, Biomet probe, clear Eli Lilly, Novartis deal: sources

BRUSSELS - EU antitrust regulators will open an extensive probe into Zimmer's $13.4 billion bid for Biomet, concerned that the creation of the world's second-largest orthopedic products group may hurt competition, three people familiar with the matter said on Thursday.

Select another date:
Search Stocks